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Page4702.InFigure2,thechemicalstructureofcompound
19 (DG-051) was incorrectly drawn as the (R)-enantiomer.
Compound 19is the (S)-enantiomer and is properly shown in
the three-dimensional crystal structure image at the right-
hand side in the corrected figure below.
On page 4704, right hand column, first paragraph, line 19
andsecondparagraphline22,(R)-prolinolshouldbechanged
to (S)-prolinol.
SupportingInformationPageS16.InTable2,thechemical
structureofcompound19(DG-051)wasincorrectlydrawnas
the (R)-enantiomer. The correct (S)-enantiomer has been
includedintherevisedversionofSupplementalTable2below.
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Figure 2. Panels showing ligand binding to LTA4H for compounds described in the manuscript. Enzyme assay IC50 values are in μM, human
whole blood cell assay IC50 values are in nM when reported, and ligand efficiency (LE) values are in kcal/(mol3heavy atom). Compound
structuresaredisplayedasyellowstickstructures,andLTA4Hisdisplayedingray.GreenmeshcorrespondstotheFo-Fc(difference)electron
density at the 3.0σ level of the crystal structure with the compound omitted from the model. Polar contacts with LTA4H and/or bound water
molecules are shown as red dashed lines. PDB IDs for each structure are indicated.Additions and Corrections Journal of Medicinal Chemistry, 2010, Vol. 53, No. 5 2331
Supplemental Table 2. Comparative IC50 data for peptidase, hydrolase, and HWB assays.
SupplementalTable2.ComparativeIC50dataforpeptidase,hydrolase,andHWBassays.Forallcompoundstructuresdescribedinthiswork,inhibition
assays were carried out using at least two independent methods, either the hydrolase assay, peptidase assay and/or a hydrolase assay in human whole
blood. See Materialsand Methodssection for details. All results are given as IC50 values in μM, with the number of replicates and the standard error of
the mean indicated where applicable.